Home > Blog > Success in rna therapies

Bold Thinking that Delivers Results for RNA Therapies

Success Stories Regulatory Submissions COVID-19 Biologics Full-Service

Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.

While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approvedveristat therapeutic centers of excellence therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.

In this piece, learn how Veristat has supported some of our Biotech Sponsors in advancing their RNA therapeutics, including:
  • A landmark RNA approval
  • Navigating a full-service COVID-19 vaccine trial
  • Ensuring a Successful Regulatory Agency Interaction

DOWNLOAD NOW

 

Meet Veristat. Learn More.


 

2 min read

Connect with Veristat at DIA 2026

Jun 5, 2026  Veristat Events

June 14-18, 2026 – Philadelphia, PA

Veristat is excited to join industry leaders and innovators at the DIA 2026 Global...

2 min read

Meet Veristat at the ASCO Annual Meeting

May 5, 2026  Veristat Events

May 29 - June 2, 2026 | Chicago, IL

▶️ At the Forefront of Oncology Progress 

Veristat is pleased to attend the ASCO...